Kiyoaki Sakata Selected Research

Kiyoaki Sakata Research Topics

Disease

9	Neoplasms (Cancer) 11/2019 - 05/2011
2	Stomach Neoplasms (Stomach Cancer) 10/2018 - 02/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2015 - 10/2013
2	Breast Neoplasms (Breast Cancer) 02/2012 - 05/2011
2	Systemic candidiasis 01/2003 - 02/2002
1	Esophageal Neoplasms (Esophageal Cancer) 11/2019
1	Disease Progression 12/2018
1	Ovarian Neoplasms (Ovarian Cancer) 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2017
1	Skin Neoplasms (Skin Cancer) 06/2017
1	Melanoma (Melanoma, Malignant) 06/2017
1	Genetic Translocation (Chromosomal Translocation) 11/2014
1	Endometrial Neoplasms (Endometrial Cancer) 05/2011
1	Lung Neoplasms (Lung Cancer) 02/2007

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2019 - 02/2012
4	Phosphotransferases (Kinase)IBA 11/2019 - 11/2014
2	Small Interfering RNA (siRNA)IBA 11/2019 - 06/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018 - 12/2015
2	Immune Checkpoint InhibitorsIBA 10/2017 - 06/2017
2	CH5183284IBA 12/2015 - 11/2014
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2015 - 11/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015 - 10/2013
2	CH5164840IBA 10/2013 - 02/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2013 - 02/2012
2	Trastuzumab (Herceptin)FDA Link 02/2012 - 05/2011
2	glycylpeptide N-tetradecanoyltransferaseIBA 01/2003 - 02/2002
2	Antifungal AgentsIBA 01/2003 - 02/2002
1	Pemetrexed (MTA)FDA Link 11/2019
1	src-Family KinasesIBA 11/2019
1	Pharmaceutical PreparationsIBA 11/2019
1	TropomyosinIBA 12/2018
1	Complementary DNA (cDNA)IBA 10/2018
1	Histone DemethylasesIBA 10/2018
1	VaccinesIBA 10/2017
1	Programmed Cell Death 1 ReceptorIBA 10/2017
1	GlypicansIBA 10/2017
1	blinatumomabIBA 10/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017
1	AntigensIBA 10/2017
1	Microphthalmia-Associated Transcription FactorIBA 06/2017
1	CH5552074IBA 06/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2015
1	onartuzumabIBA 02/2015
1	Tyrosine Kinase InhibitorsIBA 02/2015
1	ErbB Receptors (EGF Receptor)IBA 02/2015
1	Tyrosine (L-Tyrosine)FDA Link 11/2014
1	EnzymesIBA 11/2014
1	human ERBB2 proteinIBA 02/2012
1	Lapatinib (GW572016)FDA Link 02/2012
1	Molecular Chaperones (Chaperone, Molecular)IBA 02/2012
1	CH 5132799IBA 05/2011
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 05/2011
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2007
1	Ether (Diethyl Ether)IBA 01/2003
1	pyridineIBA 01/2003
1	AcidsIBA 01/2003
1	benzimidazoleIBA 01/2003
1	benzofuranIBA 02/2002

Therapy/Procedure

3	Therapeutics 10/2018 - 02/2012
1	Aftercare (After-Treatment) 12/2018
1	Immunotherapy 10/2017
1	Oral Administration 02/2012